Satish Keshav

机构：John Radcliffe Hospital, Mysore Medical College · ORCID：0000-0003-0508-8665

发表论文 281 篇 · 总被引 10907 次 · h-index 41

代表论文

• Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases (2019 · Clinical Gastroenterology and Hepatology · 被引 104)
• Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis—a Prospective Analysis (2018 · Journal of Crohn s and Colitis · 被引 80)
• Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (2020 · Nature Communications · 被引 67)
• Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis (2020 · Journal of Crohn s and Colitis · 被引 55)
• Prevalence and long‐term outcome of sub‐clinical primary sclerosing cholangitis in patients with ulcerative colitis (2020 · Liver International · 被引 31)
• Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis (2019 · Intestinal Research · 被引 22)